The FDA sent out an update on May 2 regarding drugs that are currently in shortage:
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Cefazolin Injection (Updated – Currently in Shortage)
- Cefotaxime Sodium (Claforan) Injection (Updated – Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Gemifloxacin Mesylate (Factive) Tablets (Updated – Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated – Currently in Shortage)
- Sufentanil Citrate (Sufenta) Injection (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
